{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:37:25Z","timestamp":1758040645166,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062630","R33AG057806"],"award-info":[{"award-number":["R01AG062630","R33AG057806"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL35434","U01HL105268"],"award-info":[{"award-number":["R01HL35434","U01HL105268"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.amjmed.2022.08.010","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T01:42:15Z","timestamp":1662082935000},"page":"1468-1477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor\/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-2029","authenticated-orcid":false,"given":"Mayra","family":"Tisminetzky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry H.","family":"Gurwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Tabada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Fortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisha","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thu","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjmed.2022.08.010_bib0001","first-page":"250","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials?","volume":"20","author":"Mielniczuk","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0002","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0003","unstructured":"National Clinical Guideline Centre (UK). Chronic kidney disease (partial update): early identification and management of chronic kidney disease in adults in primary and secondary care. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK248058\/. Accessed month day, year ."},{"key":"10.1016\/j.amjmed.2022.08.010_bib0004","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40264-014-0160-0","article-title":"Adherence to renal function monitoring guidelines in patients starting antihypertensive therapy with diuretics and RAAS inhibitors: a retrospective cohort study","volume":"37","author":"van Blijderveen","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0006","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pds.1217","article-title":"Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers","volume":"16","author":"Raebel","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012818","article-title":"Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study","volume":"7","author":"Schmidt","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0008","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11606-009-1228-x","article-title":"Diabetes and drug-associated hyperkalemia: effect of potassium monitoring","volume":"25","author":"Raebel","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0009","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/pds.1935","article-title":"Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care","volume":"19","author":"McDowell","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.amjmed.2022.08.010_bib0010","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0011","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0012","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000138934.28340.ED","article-title":"National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction","volume":"110","author":"Masoudi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.327.7414.513","article-title":"Polypharmacy and comorbidity in heart failure: most patients have comorbidities that need to be addressed","volume":"327","author":"Masoudi","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.amjmed.2022.08.010_bib0014","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cger.2016.01.014","article-title":"Magnitude and impact of multimorbidity on clinical outcomes in older adults with cardiovascular disease: a literature review","volume":"32","author":"Tisminetzky","year":"2016","journal-title":"Clin Geriatr Med"},{"issue":"7","key":"10.1016\/j.amjmed.2022.08.010_bib0015","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.amjmed.2022.08.010_bib0016","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11606-012-2072-y","article-title":"The average lifespan of patients discharged from hospital with heart failure","volume":"27","author":"Alter","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.amjmed.2022.08.010_bib0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11606-011-1930-3","article-title":"Impact of comorbidity on mortality among older persons with advanced heart failure","volume":"27","author":"Ahluwalia","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.08.010_bib0018","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey","volume":"16","author":"van Deursen","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.amjmed.2022.08.010_bib0019","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jchf.2015.03.004","article-title":"burden of comorbidities and functional and cognitive impairments in elderly patients at the initial diagnosis of heart failure and their impact on total mortality: the cardiovascular health study","volume":"3","author":"Murad","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.amjmed.2022.08.010_bib0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.amjmed.2022.08.010_bib0021","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11606-011-1725-6","article-title":"Change in comorbidity prevalence with advancing age among persons with heart failure","volume":"26","author":"Ahluwalia","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.amjmed.2022.08.010_bib0022","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.amjopharm.2012.04.003","article-title":"Influence of patient age and comorbid burden on clinician attitudes toward heart failure guidelines","volume":"10","author":"Steinman","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"10","key":"10.1016\/j.amjmed.2022.08.010_bib0023","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.294.10.1240","article-title":"Risk-treatment mismatch in the pharmacotherapy of heart failure","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjmed.2022.08.010_bib0024","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCOUTCOMES.108.801654","article-title":"The cardiovascular research network: a new paradigm for cardiovascular quality and outcomes research","volume":"1","author":"Go","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.amjmed.2022.08.010_bib0025","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/14779072.6.8.1043","article-title":"Creating a research data network for cardiovascular disease: the CVRN","volume":"6","author":"Magid","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.amjmed.2022.08.010_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jgs.12062","article-title":"Patterns of comorbidity in older adults with heart failure: the cardiovascular research network PRESERVE study","volume":"61","author":"Saczynski","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"17","key":"10.1016\/j.amjmed.2022.08.010_bib0027","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.296.17.2105","article-title":"Statin therapy and risks for death and hospitalization in chronic heart failure","volume":"296","author":"Go","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjmed.2022.08.010_bib0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MLR.0000000000000853","article-title":"Defining multiple chronic conditions for quality measurement","volume":"56","author":"Drye","year":"2018","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.amjmed.2022.08.010_bib0029","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/MLR.0000000000000026","article-title":"Beyond comorbidity: expanding the definition and measurement of complexity among older adults using administrative claims data","volume":"52","author":"Chrischilles","year":"2014","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.amjmed.2022.08.010_bib0030","first-page":"1049","article-title":"The HMO research network virtual data warehouse: a public data model to support collaboration","volume":"2","author":"Ross","year":"2014","journal-title":"EGEMS (Wash DC)"},{"issue":"9","key":"10.1016\/j.amjmed.2022.08.010_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006415","article-title":"Kidney Function and potassium monitoring after initiation of renin-angiotensin-aldosterone system blockade therapy and outcomes in 2 north american populations","volume":"13","author":"Parikh","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0032","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","article-title":"Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions","volume":"55","author":"Levey","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0033","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0034","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.kint.2016.09.038","article-title":"Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes","volume":"91","author":"Clase","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0036","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jcpt.12109","article-title":"Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?","volume":"39","author":"Park","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0037","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0038","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0039","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.08.010_bib0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5032\/jae.2011.01132","article-title":"Reporting and interpreting effect size in quantitative agricultural education research","volume":"52","author":"Kotrlik","year":"2011","journal-title":"J Agric Educ"},{"year":"2014","series-title":"Designing and Conducting Survey Research: A Comprehensive Guide","author":"Rea","key":"10.1016\/j.amjmed.2022.08.010_bib0041"},{"key":"10.1016\/j.amjmed.2022.08.010_bib0042","doi-asserted-by":"crossref","unstructured":"Garlo KG, Bates DW, Seger DL, Fiskio JM, Charytan DM. Association of changes in creatinine and potassium levels after initiation of renin angiotensin aldosterone system inhibitors with emergency department visits, hospitalizations, and mortality in individuals with chronic kidney disease. JAMA Netw Open. 2018;1(7):e183874. doi: 10.1001\/Jamanetworkopen.2018.3874.","DOI":"10.1001\/jamanetworkopen.2018.3874"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322006313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322006313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:28:40Z","timestamp":1757582920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322006313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0002934322006313"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.08.010","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor\/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}